XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment
Beginning balance (in shares) at Dec. 26, 2021     109,345,697      
Beginning balance at Dec. 26, 2021 $ 653,117 $ (4,944) $ 109 $ 1,129,224 $ (476,216) $ (4,944)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (190,441)       (190,441)  
Issuance of common stock related to restricted shares (in shares)     829,679      
Issuance of common stock related to restricted shares 0   $ 1 (1)    
Stock-based compensation expense 78,736     78,736    
Exercise of stock options (in shares)     957,617      
Exercise of stock options 4,758   $ 1 4,757    
Ending balance (in shares) at Dec. 25, 2022     111,132,993      
Ending balance at Dec. 25, 2022 $ 541,226   $ 111 1,212,716 (671,601)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-02 [Member]          
Net loss $ (113,384)       (113,384)  
Issuance of common stock related to restricted shares (in shares)     587,078      
Issuance of common stock related to restricted shares 0   $ 0 0    
Stock-based compensation expense $ 49,532     49,532    
Exercise of stock options (in shares) 929,963   929,963      
Exercise of stock options $ 5,389   $ 2 5,387    
Shares repurchased for employee tax withholding (in shares)     (10,888)      
Shares repurchased for employee tax withholding (166)     (166)    
Ending balance (in shares) at Dec. 31, 2023     112,639,146      
Ending balance at Dec. 31, 2023 482,597   $ 113 1,267,469 (784,985)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (90,373)       (90,373)  
Issuance of common stock related to restricted shares (in shares)     479,078      
Stock-based compensation expense 39,024     39,024    
Issuance of common stock related to performance stock units $ 2   $ 2      
Issuance of common stock related to performance stock units (in shares) 1,800,000          
Issuance of common stock related to Spyce milestone achievement $ 2,132     2,132    
Issuance of common stock related to Spyce milestone achievement (in shares) 208,042          
Exercise of stock options (in shares) 1,990,576   1,990,576      
Exercise of stock options $ 12,765   $ 2 12,763    
Shares repurchased for employee tax withholding (in shares)     (531)      
Shares repurchased for employee tax withholding (2)     (2)    
Ending balance (in shares) at Dec. 29, 2024     117,116,311      
Ending balance at Dec. 29, 2024 $ 446,145   $ 117 $ 1,321,386 $ (875,358)